TGR-1202, a next generation PI3K-delta inhibitor in CLL and B-cell lymphomas
ASH 2015 highlights in multiple myeloma by Prof. Ola Landgren
The azacitidine plus romidepsin clinical trial in lymphoid malignancies
Round table with Prof. John Gribben and Prof. Stephan Stilgenbauer on CLL
John Gribben et al.
Negative-data clinical trials in lymphoma presented at ASH 2015